V
Power Law company profile
Veloxis Pharmaceuticals
Biotech & Life Sciences · Cary, United States · Founded 2002 · IPO 2006 Unicorn
Valuation
$1.30B
Market cap · 2026
Global footprint
Where Veloxis Pharmaceuticals has talent and traffic
Web traffic by country
4.9K
monthly visits
across markets
across markets
🇺🇸 United States61.2%
🇮🇳 India8.2%
🇯🇵 Japan2%
Patent intelligence
$16M patent portfolio · 10 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$16M
1.3% of market cap · comparable to top peer Sinovent ($17M)
10 active patent families
Where Veloxis Pharmaceuticals innovates
Pharmaceutical SubstancesTacrolimusBioavailabilityOrganic chemistryFenofibrate
Above peer median on Legal, Strategic, Market, Economic, Technology
Quality vs same-sector peers
Veloxis Pharmaceuticals on the five Patsnap quality dimensions
Veloxis Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Veloxis Pharmaceuticals concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Veloxis Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Veloxis Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.